Moderna
MRNA
#1154
Rank
NZ$34.70 B
Marketcap
NZ$87.50
Share price
-3.03%
Change (1 day)
97.42%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Total assets

Total assets on the balance sheet as of December 2025 : NZ$21.06 Billion

According to Moderna 's latest financial reports the company's total assets are NZ$21.06 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Moderna - Total assets on balance sheet (from 2017 to 2025)

Total assets by year

Year Total assets Change
2025-12-31NZ$21.30 B-15.04%
2024-12-31NZ$25.07 B-13.94%
2023-12-31NZ$29.13 B-28.46%
2022-12-31NZ$40.72 B12.77%
2021-12-31NZ$36.11 B255.18%
2020-12-31NZ$10.16 B330.87%
2019-12-31NZ$2.36 B-19.32%
2018-12-31NZ$2.92 B91.56%
2017-12-31NZ$1.52 B-25.36%
2016-12-31NZ$2.04 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
NZ$340.11 B 1,514.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$189.42 B 799.25%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
NZ$233.67 B 1,009.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
NZ$0.12 B-99.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
NZ$12.68 M-99.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$8.47 B-59.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
NZ$2.73 B-87.00%๐Ÿ‡บ๐Ÿ‡ธ USA